These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 19160144

  • 1. The effect of K-ATP channel blockage during erythropoietin treatment in renal ischemia-reperfusion injury.
    Yazihan N, Ataoglu H, Kavas GO, Akyurek N, Yener B, Aydm C.
    J Invest Surg; 2008; 21(6):340-7. PubMed ID: 19160144
    [Abstract] [Full Text] [Related]

  • 2. ATP-dependent K+ channels in renal ischemia reperfusion injury.
    Rahgozar M, Willgoss DA, Gobé GC, Endre ZH.
    Ren Fail; 2003 Nov; 25(6):885-96. PubMed ID: 14669848
    [Abstract] [Full Text] [Related]

  • 3. Role of ATP-dependent K channels in the effects of erythropoietin in renal ischaemia injury.
    Yilmaz TU, Yazihan N, Dalgic A, Kaya EE, Salman B, Kocak M, Akcil E.
    Indian J Med Res; 2015 Jun; 141(6):807-15. PubMed ID: 26205024
    [Abstract] [Full Text] [Related]

  • 4. The role of ATP-sensitive potassium channel blockers in ischemia-reperfusion-induced renal injury versus their effects on cardiac ischemia reperfusion in rats.
    Tawfik MK, Abo-Elmatty DM, Ahmed AA.
    Eur Rev Med Pharmacol Sci; 2009 Jun; 13(2):81-93. PubMed ID: 19499842
    [Abstract] [Full Text] [Related]

  • 5. The ATP-sensitive potassium channel blocker glibenclamide prevents renal ischemia/reperfusion injury in rats.
    Pompermayer K, Souza DG, Lara GG, Silveira KD, Cassali GD, Andrade AA, Bonjardim CA, Passaglio KT, Assreuy J, Cunha FQ, Vieira MA, Teixeira MM.
    Kidney Int; 2005 May; 67(5):1785-96. PubMed ID: 15840025
    [Abstract] [Full Text] [Related]

  • 6. The role of KATP channels on propofol preconditioning in a cellular model of renal ischemia-reperfusion.
    Assad AR, Delou JM, Fonseca LM, Villela NR, Nascimento JH, Verçosa N, Lopes AG, Capella MA.
    Anesth Analg; 2009 Nov; 109(5):1486-92. PubMed ID: 19843786
    [Abstract] [Full Text] [Related]

  • 7. Selective cardiac plasma-membrane K(ATP) channel inhibition is defibrillatory and improves survival during acute myocardial ischemia and reperfusion.
    Vajda S, Baczkó I, Leprán I.
    Eur J Pharmacol; 2007 Dec 22; 577(1-3):115-23. PubMed ID: 17904545
    [Abstract] [Full Text] [Related]

  • 8. Blocking of the ATP sensitive potassium channel ameliorates the ischaemia-reperfusion injury in the rat testis.
    Shimizu S, Oikawa R, Tsounapi P, Inoue K, Shimizu T, Tanaka K, Martin DT, Honda M, Sejima T, Tomita S, Saito M.
    Andrology; 2014 May 22; 2(3):458-65. PubMed ID: 24604784
    [Abstract] [Full Text] [Related]

  • 9. Erythropoietin administration is associated with short-term improvement in glomerular filtration rate after ischemia-reperfusion injury.
    Sølling C, Christensen AT, Krag S, Frøkiaer J, Wogensen L, Krog J, Tønnesen EK.
    Acta Anaesthesiol Scand; 2011 Feb 22; 55(2):185-95. PubMed ID: 21226860
    [Abstract] [Full Text] [Related]

  • 10. Erythropoietin attenuates apoptosis after ischemia-reperfusion-induced renal injury in transiently hyperglycemic Wister rats.
    Caetano AM, Vianna Filho PT, Castiglia YM, Golim MA, de Souza AV, de Carvalho LR, Deffune E, de Oliveira C, Vianna PT.
    Transplant Proc; 2011 Dec 22; 43(10):3618-21. PubMed ID: 22172815
    [Abstract] [Full Text] [Related]

  • 11. Erythropoietin attenuates hydrogen peroxide-induced damage of hepatocytes.
    Yazihan N, Ataoğlu H, Yener B, Aydin C.
    Turk J Gastroenterol; 2007 Dec 22; 18(4):239-44. PubMed ID: 18080920
    [Abstract] [Full Text] [Related]

  • 12. Erythropoietin ameliorates renal ischemia and reperfusion injury via inhibiting tubulointerstitial inflammation.
    Hu L, Yang C, Zhao T, Xu M, Tang Q, Yang B, Rong R, Zhu T.
    J Surg Res; 2012 Jul 22; 176(1):260-6. PubMed ID: 21816412
    [Abstract] [Full Text] [Related]

  • 13. The renal protect function of erythropoietin after release of bilateral ureteral obstruction in a rat model.
    Ren CC, Zhu W, Wang QW, Lu YT, Wang Y, Zhang GX, Xie JF, Wu JW, Jia ZM, Zhang T, Su ZQ, Wen JG.
    Clin Sci (Lond); 2018 Sep 28; 132(18):2071-2085. PubMed ID: 29959186
    [Abstract] [Full Text] [Related]

  • 14. Erythropoietin Administration Promotes Expression of VEGF in Renal Ischemic–Reperfusion Injury in Rat Model.
    Kongkham S, Sriwong S, Tasanarong A.
    J Med Assoc Thai; 2016 Jul 28; 99 Suppl 4():S246-55. PubMed ID: 29927177
    [Abstract] [Full Text] [Related]

  • 15. The mechanism of preventive effect of captopril on renal ischemia reperfusion injury is independent of ATP dependent potassium channels.
    Habibey R, Ajami M, Hesami A, Pazoki-Toroudi H.
    Iran Biomed J; 2008 Oct 28; 12(4):241-5. PubMed ID: 19079539
    [Abstract] [Full Text] [Related]

  • 16. The improvement of ischemia/reperfusion injury by erythropoetin is not mediated through bone marrow cell recruitment in rats.
    Esposito C, Pertile E, Grosjean F, Castoldi F, Diliberto R, Serpieri N, Arra M, Villa L, Mangione F, Esposito V, Migotto C, Valentino R, Dal Canton A.
    Transplant Proc; 2009 May 28; 41(4):1113-5. PubMed ID: 19460493
    [Abstract] [Full Text] [Related]

  • 17. Erythropoietin Receptor Activation Protects the Kidney From Ischemia/Reperfusion-Induced Apoptosis by Activating ERK/p53 Signal Pathway.
    Zou YR, Zhang J, Wang J, Peng L, Li GS, Wang L.
    Transplant Proc; 2016 May 28; 48(1):217-21. PubMed ID: 26915871
    [Abstract] [Full Text] [Related]

  • 18. EPO and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney.
    Gong H, Wang W, Kwon TH, Jonassen T, Li C, Ring T, FrøkiAEr J, Nielsen S.
    Kidney Int; 2004 Aug 28; 66(2):683-95. PubMed ID: 15253723
    [Abstract] [Full Text] [Related]

  • 19. An ATP-sensitive potassium channel blocker suppresses sodium-induced hypertension through increased secretion of urinary kallikrein.
    Kamata Y, Fujita T, Kato T, Hayashi I, Kurosaka M, Katori M, Fujita Y, Majima M.
    Hypertens Res; 2009 Mar 28; 32(3):220-6. PubMed ID: 19262486
    [Abstract] [Full Text] [Related]

  • 20. Recombinant human erythropoietin pretreatment attenuates acute renal tubular injury against ischemia-reperfusion by restoring transient receptor potential channel-6 expression and function in collecting ducts.
    Shen S, Jin Y, Li W, Liu X, Zhang T, Xia W, Wang Y, Ma K.
    Crit Care Med; 2014 Oct 28; 42(10):e663-72. PubMed ID: 25072760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.